Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.
Review of literature of individual case reports of BRAF V600 tumors treated with BRAF plus or minus MEK inhibitor. Table shows percentage of cases using each drug(s).
| Dabrafenib (BRAF) | 34% (n = 56) |
| Dabrafenib plus trametinib (BRAF plus MEK) | 16% (n = 27) |
| Trametinib (MEK) | 4% (n = 6) |
| Vemurafenib (BRAF) | 44% (n = 72) |
| Vemurafenib plus trametinib (BRAF plus MEK) | 1% (n = 1) |
| Vemurafenib plus cobimetinib (BRAF plus MEK) | 2% (n = 3) |
